Ufl1 and Ufbp1 play critical roles in preventing liver fibrosis, steatohepatitis, and HCC by acting as inhibitors of the mTOR pathway, highlighting their potential as therapeutic targets for liver diseases (89). The gene discussed is MTOR; the disease is hepatocellular carcinoma.